Immix Biopharma
IMMX
IMMX
12 hedge funds and large institutions have $730K invested in Immix Biopharma in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 9
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$181K | |
| 2 | +$32.3K | |
| 3 | +$19.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$7.57K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.8K |
Top Sellers
| 1 | -$154K | |
| 2 | -$76.9K | |
| 3 | -$58K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$43.9K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$36K |